The role of post-translationally modified antigen in rheumatoid arthritis

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Rheumatoid arthritis (RA) is an inflammatory disease of joints. People who get RA often develop antibodies which react against proteins found in inflamed joints. We will investigate why cells of the immune system react against these proteins in RA, and identify which joint proteins, especially abnormal proteins, are targeted. This will allow us to design new approaches to treat RA in a way that just targets the response to these abnormal proteins, rather than the entire immune system.

Funded Activity Details

Start Date: 01-01-2008

End Date: 01-01-2010

Funding Scheme: NHMRC Project Grants

Funding Amount: $609,535.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Emergency medicine

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Arthritis and pathology | Rheumatoid arthritis | T cell immunity | X-ray crystallography | autoimmune diseases | biochemistry- protein peptide | proteomics | rheumatoid arthritis